# Troubleshooting out-of-range QC results antimicrobial susceptibility testing ## Quick Answer - When QC results fall outside acceptable ranges, document the failure, halt reporting of patient results, and begin a systematic root-cause investigation before repeating the test. - Follow a structured sequence that checks inoculum preparation, media quality, reagent integrity, instrument function, and operator technique, with corrective actions at each step. - Out-of-range QC results can stem from multiple interacting causes, so a single repeat test without root-cause analysis may mask an ongoing system failure and risk regulatory noncompliance. ## At a Glance Antimicrobial susceptibility testing (AST) depends on precise, reproducible conditions to generate minimum inhibitory concentration (MIC) values that guide clinical decisions. Quality control (QC) strains with known expected ranges serve as sentinels for the entire testing system. When QC results fall outside these ranges, the laboratory must determine whether the problem lies in the organism, the media, the reagents, the instrument, or the operator before patient results can be trusted. | QC Failure Category | Common Causes | Initial Corrective Action | Escalation Criteria | | --- | --- | --- | --- | | Inoculum preparation errors | Incorrect turbidity standard, expired or contaminated inoculum, improper dilution | Prepare fresh inoculum from pure culture and verify turbidity | Repeat failure with fresh reagents requires full root-cause analysis | | Media or reagent problems | Expired plates, improper storage, contaminated batches, lot-to-lot variation | Check expiration dates, storage logs, and lot numbers against QC records | Multiple lots failing simultaneously indicates systemic issue | | Instrument malfunction | Temperature drift, calibration errors, reader or incubator failure | Run instrument calibration checks and review maintenance logs | Persistent failure after recalibration requires manufacturer service | | Operator technique variation | Inconsistent inoculation, improper disk placement, timing errors | Retrain staff and observe technique against standard operating procedure | Discrepancies between operators indicate training gap | ## Understanding QC in Antimicrobial Susceptibility Testing Quality control in antimicrobial susceptibility testing serves as the foundation for reliable MIC results. The Clinical and Laboratory Standards Institute (CLSI) publishes standards that define acceptable QC ranges for antimicrobial agents tested against designated reference strains. These standards-based approaches ensure that results generated in one laboratory can be compared meaningfully with those from another laboratory. The [CLSI antimicrobial susceptibility testing standards](https://clsi.org/standards/products/microbiology) provide the framework for establishing and maintaining QC programs in clinical and research laboratories. Reference strains used for QC purposes must be authenticated and traceable. The [American Type Culture Collection](https://www.atcc.org/) maintains characterized biological materials that serve as standard QC organisms. These authenticated strains carry documented phenotypic characteristics that make them suitable for monitoring AST performance. Using uncharacterized or passaged strains undermines the validity of the entire QC process because the expected results are no longer predictable. The global context for antimicrobial susceptibility testing extends beyond individual laboratory quality control. The [World Health Organization antimicrobial resistance program](https://www.who.int/health-topics/antimicrobial-resistance) monitors resistance patterns worldwide and emphasizes the importance of reliable susceptibility data for surveillance and stewardship. Laboratories that produce inaccurate AST results contribute misleading information to local, national, and global resistance databases, potentially distorting treatment guidelines and public health interventions. ## Core Principles of QC Failure Investigation ### The QC Strain as a System Sentinel A QC organism with a known expected MIC range functions as a biological indicator for the entire testing pathway. When this organism produces results outside its documented range, the failure indicates that something in the system has changed. The QC strain does not tell you what changed, only that the system is no longer performing within established parameters. The [Bacteriological Analytical Manual](https://www.fda.gov/food/laboratory-methods-food/bacteriological-analytical-manual-bam) from the FDA describes similar quality principles for food microbiology testing. While the specific methods differ from clinical AST, the underlying concept remains consistent: reference materials with known characteristics allow laboratories to verify that their testing systems produce accurate results. This principle applies across microbiology disciplines. ### The Difference Between Accuracy and Precision A laboratory can be precise without being accurate. Precision means that repeated tests produce similar results. Accuracy means that those results match the true value. QC failures can involve either problem. A systematic error shifts all results in one direction, producing inaccurate but potentially precise results. A random error produces inconsistent results that may average out to the correct value but cannot be trusted for individual patient samples. Understanding this distinction guides the troubleshooting approach. Systematic errors often trace to a single correctable cause such as expired media or a miscalibrated instrument. Random errors suggest technique variation, contamination, or intermittent equipment malfunction. The pattern of QC failures across multiple runs provides clues about which type of error is occurring. ### The Role of Documentation in Troubleshooting Complete records transform troubleshooting from guesswork into systematic investigation. Laboratories should maintain logs that capture the date and time of each QC test, the operator, the lot numbers of all reagents and media, the instrument used, and the results obtained. When a failure occurs, these records allow the investigator to identify patterns that might otherwise remain invisible. The [American Society for Microbiology](https://asm.org/) emphasizes the importance of standardized laboratory practices and professional development in microbiology. Documentation practices are a core component of professional laboratory operation. Without adequate records, troubleshooting becomes dependent on memory and anecdote instead of evidence. ## Systematic Root-Cause Analysis Workflow ### Step 1: Confirm the Failure Before initiating a full investigation, confirm that the QC result actually falls outside the acceptable range. This step sounds obvious but is frequently skipped in practice. Transcription errors, misidentification of the QC organism, or reading results from the wrong column of a table can all produce apparent failures that do not reflect actual system problems. Verify the expected range against the current standard. Ranges can change when standards are updated, and using an outdated table can produce false failures. The [CLSI standards](https://clsi.org/standards/products/microbiology) are periodically revised, and laboratories must ensure they are working from the current edition. ### Step 2: Isolate the Variable Once the failure is confirmed, determine whether the problem affects a single antimicrobial agent, a group of agents, or all agents tested. This information narrows the investigation considerably. A single agent failing suggests a problem with that specific antimicrobial disk, well, or reagent. A group of agents failing may indicate a problem with a class of compounds or a specific panel. All agents failing points to a systemic issue such as inoculum preparation, media quality, or instrument function. ### Step 3: Check the Obvious Causes First The most common causes of QC failure are also the easiest to identify and correct. Check the expiration dates on all media and reagents. Verify that storage conditions meet manufacturer specifications. Confirm that the correct QC strain was used and that it was subcultured appropriately. The [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html) guidelines from CDC and NIH describe proper handling procedures for biological materials. While these guidelines focus primarily on safety, they also address the importance of maintaining culture integrity through proper handling and storage practices. ### Step 4: Examine Inoculum Preparation Inoculum preparation is a frequent source of QC failures. The turbidity standard used to adjust inoculum density must be fresh and properly prepared. An expired or contaminated turbidity standard produces an inoculum that is either too dense or too dilute, shifting MIC results in predictable directions. The timing between inoculum preparation and plate inoculation matters. Organisms continue to grow during the interval, so delays can increase the effective inoculum density. Standard procedures specify a maximum time between preparation and inoculation, and exceeding this window can produce out-of-range results. ### Step 5: Evaluate Media Quality Agar depth, moisture content, and surface condition all affect antimicrobial diffusion and organism growth. Plates that are too dry produce poor growth and unreliable zones. Plates that are too wet allow excessive diffusion and produce falsely large zones of inhibition. Media pH is another critical variable. Most antimicrobial agents have optimal activity within a narrow pH range. Media that is too acidic or too alkaline can shift MIC values outside acceptable ranges. Laboratories should verify that media lots meet specifications before use and should investigate any QC failures that coincide with a change in media lot. ### Step 6: Assess Instrument Function Automated AST systems depend on precise temperature control, accurate optical readings, and reliable mechanical function. Temperature drift in an incubator can slow or accelerate organism growth, shifting results. Optical calibration errors can produce incorrect readings of growth or inhibition. The [total laboratory automation review](https://doi.org/10.3343/alm.2024.0581) describes how automated systems integrate pre-analytical, analytical, and post-analytical phases in clinical laboratories. These systems enhance quality control through error minimization, but they also introduce new failure modes that require systematic troubleshooting. Instrument maintenance logs and calibration records are essential tools for identifying equipment-related QC failures. ### Step 7: Review Operator Technique Human error remains a significant source of QC failures. Inconsistent inoculation pressure, improper disk placement, and timing errors all produce out-of-range results. When multiple operators perform AST, technique variation can create patterns of failure that correlate with specific individuals. Direct observation of operator technique against the standard operating procedure can identify deviations that produce QC failures. Retraining should focus on the specific steps where technique drift has occurred instead of repeating general training content. ## Mermaid Flowchart for QC Failure Investigation ```mermaid flowchart TD A[QC Result Out of Range] --> B{Confirm Failure} B -->|No| C[Check Transcription and Range Table] B -->|Yes| D{Pattern of Failure} D -->|Single Agent| E[Check Specific Reagent or Disk] D -->|Agent Group| F[Check Panel or Class Reagents] D -->|All Agents| G[Check Systemic Factors] E --> H{Expired or Damaged?} F --> H G --> I[Check Inoculum Preparation] G --> J[Check Media Quality] G --> K[Check Instrument Function] H -->|Yes| L[Replace and Repeat QC] H -->|No| M[Check Storage Conditions] I --> N{Correct Procedure?} J --> O{Within Specifications?} K --> P{Calibration Valid?} N -->|No| Q[Retrain and Repeat QC] O -->|No| R[Replace Media and Repeat QC] P -->|No| S[Recalibrate and Repeat QC] N -->|Yes| T[Escalate to Full Investigation] O -->|Yes| T P -->|Yes| T L --> U[Document and Monitor] Q --> U R --> U S --> U T --> V[Review All Records and Consult Manufacturer] ``` ## Practical Implementation Steps ### Establishing a QC Failure Response Protocol Every laboratory performing AST should have a written protocol for responding to QC failures. This protocol should specify who is notified, what documentation is required, and under what circumstances patient results are withheld. The protocol should be reviewed and approved before failures occur so that response is automatic instead of improvised. The protocol should define the point at which the laboratory stops reporting patient results. This decision has clinical consequences, so it should be made according to predetermined criteria instead of in the moment. Delaying patient results while troubleshooting is preferable to releasing potentially inaccurate results that could lead to inappropriate therapy. ### Conducting the Initial Investigation The initial investigation should follow the systematic workflow described above, moving from confirmation of the failure through the most common causes to less common ones. Each step should be documented, including what was checked, what was found, and what action was taken. Time limits for the initial investigation should be established. If the cause is not identified within a defined period, the investigation should escalate to include manufacturer technical support or consultation with reference laboratory personnel. Prolonged troubleshooting without progress wastes time and delays patient care. ### Implementing Corrective Actions Corrective actions should address the identified root cause instead of simply repeating the test. If expired media caused the failure, replace the media and verify that other plates from the same lot have been removed from use. If operator technique caused the failure, retrain the operator and verify competency before allowing independent testing. After corrective action, repeat QC testing to verify that the system is performing within acceptable ranges. The number of repeat tests required depends on the nature of the failure and the requirements of the laboratory's quality program. A single successful repeat may be sufficient for an obvious cause such as expired media, while a more complex failure may require multiple consecutive successful runs. ### Documenting the Investigation Complete documentation of the QC failure investigation serves multiple purposes. It provides evidence of regulatory compliance, supports continuous quality improvement, and creates a reference for future troubleshooting. The documentation should include the date and time of the failure, the QC organism and antimicrobial agent involved, the observed and expected results, the investigation steps taken, the root cause identified, and the corrective action implemented. The [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html) guidelines emphasize the importance of maintaining accurate records in laboratory operations. While the primary focus of these guidelines is safety, the documentation principles apply equally to quality activities. ## Records and Measurements ### Essential Records for QC Troubleshooting | Record Type | Information Captured | Troubleshooting Value | | --- | --- | --- | | QC testing log | Date, operator, organism, antimicrobial agent, result | Identifies temporal patterns and operator correlations | | Media and reagent logs | Lot numbers, expiration dates, receipt dates, storage conditions | Traces failures to specific lots or storage deviations | | Instrument maintenance records | Calibration dates, service history, error messages | Correlates failures with equipment events | | Temperature monitoring logs | Incubator and refrigerator temperatures over time | Detects temperature excursions that affect results | | Operator training records | Training dates, competency assessments, retraining events | Links failures to training gaps or recent changes | ### Measurements That Support Troubleshooting Quantitative measurements provide objective data for troubleshooting. Inoculum density measurements confirm that the correct number of organisms was used. Zone diameter measurements for disk diffusion testing provide precise values that can be compared with expected ranges. MIC values from broth dilution methods provide similar quantitative data. Trend analysis of QC results over time can reveal gradual drift before results fall outside acceptable ranges. A QC result that remains within range but moves consistently in one direction over multiple runs may indicate an emerging problem. Monitoring these trends allows corrective action before a formal QC failure occurs. ## Common Failure Patterns ### Single-Day Failures A QC failure that occurs on a single day and does not recur often traces to a transient cause such as a contaminated inoculum, an error in preparation, or a temporary instrument malfunction. These failures are concerning but less alarming than persistent failures because they suggest the problem has resolved. However, a single-day failure should not be dismissed without investigation. The cause may be an intermittent problem that will recur unpredictably. The investigation should be thorough enough to identify the cause or to establish that the failure was an isolated event with a clear explanation. ### Recurring Failures with the Same Organism When the same QC organism fails repeatedly, the problem may lie with the organism itself. Reference strains can change over time through mutation or contamination. The [American Type Culture Collection](https://www.atcc.org/) provides authenticated strains with documented characteristics, but even authenticated strains can change if handled improperly. Subculturing practices affect strain stability. Excessive passage can select for variants with altered susceptibility profiles. Laboratories should follow recommended subculture limits and replace QC strains according to established schedules. ### Recurring Failures with the Same Antimicrobial Agent A specific antimicrobial agent that fails repeatedly across different QC organisms points to a problem with that agent or its testing materials. Expired or improperly stored disks or wells can lose potency. Manufacturing defects can affect an entire lot. When a specific agent fails, check whether the problem affects multiple lots of testing materials. If all lots fail, the problem may lie in the testing method itself or in the expected range. Consultation with the standard-setting organization or the manufacturer may be necessary. ### Failures Across Multiple Agents and Organisms Widespread failures affecting multiple agents and organisms indicate a systemic problem. Inoculum preparation errors, media quality issues, and instrument malfunctions are the most likely causes. These failures require immediate action because they compromise all AST results generated during the affected period. The investigation should prioritize identifying the systemic cause before any patient results are reported. This situation represents the highest urgency in QC troubleshooting because the potential impact on patient care is greatest. ## Options and Tradeoffs in Troubleshooting Approaches ### Repeat Testing Versus Root-Cause Investigation The simplest response to a QC failure is to repeat the test. This approach is appropriate when the cause is obvious and easily corrected, such as an expired reagent that is replaced before the repeat test. However, repeating the test without identifying the root cause risks repeating the same failure if the underlying problem persists. The tradeoff between speed and thoroughness must be managed carefully. Repeating the test is faster and may resolve the immediate problem, but it does not prevent future failures. A root-cause investigation takes longer but addresses the underlying issue. Laboratories should use repeat testing as a verification step after corrective action instead of as a substitute for investigation. ### In-House Investigation Versus Manufacturer Support Many QC failures can be resolved through in-house investigation using the systematic workflow described above. However, some failures require manufacturer involvement. Instrument malfunctions that persist after basic troubleshooting, media problems that affect multiple lots, and failures that cannot be explained after thorough investigation all warrant manufacturer support. The decision to involve the manufacturer should be made according to predetermined criteria instead of after prolonged unsuccessful troubleshooting. Manufacturer technical support can provide specialized knowledge and access to information that is not available to laboratory staff. ### Continuing Versus Suspending Patient Testing The decision to continue or suspend patient testing during QC troubleshooting has significant clinical implications. Suspending testing delays results for patients who may need therapy adjustments. Continuing testing risks reporting inaccurate results. This decision should be guided by the nature and extent of the QC failure. A failure affecting a single antimicrobial agent may allow continued testing with the affected agent reported with a caution or withheld pending resolution. A systemic failure affecting all agents requires suspension of testing until the problem is resolved. ## Quality and Welfare Controls ### Biosafety Considerations During Troubleshooting QC troubleshooting often involves handling reference strains and potentially contaminated materials. The [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html) guidelines from CDC and NIH provide the framework for safe handling of biological materials. Laboratories should follow appropriate containment practices for the organisms being handled and should decontaminate materials according to established protocols. Reference strains used for QC are generally well-characterized and present lower risk than clinical isolates. However, the same biosafety principles apply. Proper hand hygiene, personal protective equipment, and decontamination procedures protect laboratory staff and prevent cross-contamination that could compromise QC results. ### Preventing Cross-Contamination During Investigation Cross-contamination can produce false QC failures or mask the true cause of a failure. Contaminated media, reagents, or instruments can introduce organisms that interfere with AST results. The investigation should consider the possibility of contamination and should include appropriate checks. Reviewing aseptic technique during the investigation can identify opportunities for contamination. Plates that show unexpected colony morphology, mixed growth, or contamination in negative control wells suggest that contamination may be contributing to the problem. ### Staff Competency and Training Operator technique is a common cause of QC failures, and training is a common corrective action. The [American Society for Microbiology](https://asm.org/) supports professional development and competency assessment for microbiology laboratory personnel. Training should be specific to the identified problem and should include verification that the operator can perform the procedure correctly. Competency assessment should include direct observation of technique, review of results from test samples, and evaluation of problem-solving skills. Retraining should be documented and should include a period of increased oversight before the operator returns to independent testing. ## Limitations and Evidence Considerations ### Limitations of QC Testing QC testing has inherent limitations that should be understood when interpreting results. QC strains represent a limited set of organisms and antimicrobial agents. A QC result within the acceptable range does not guarantee that all patient results are accurate, and a QC result outside the acceptable range does not necessarily mean that all patient results are wrong. The [comparison study of rapid AST systems](https://doi.org/10.1128/jcm.01073-25) demonstrates that even FDA-cleared automated systems show categorical agreement rates around 94 percent and essential agreement rates around 96 percent when compared with each other. Discrepancies between systems occur even when both systems are functioning within their specified QC parameters. This finding underscores the importance of understanding the limitations of any testing system. ### The Role of Emerging Technologies Rapid AST systems and total laboratory automation are changing the landscape of antimicrobial susceptibility testing. The [total laboratory automation review](https://doi.org/10.3343/alm.2024.0581) describes how automated systems integrate multiple phases of laboratory testing and enhance quality control through error minimization. These systems introduce new QC considerations, including the need to verify that automation does not introduce systematic errors. The [rapid AST system comparison](https://doi.org/10.1128/jcm.01073-25) shows that newer systems can provide results in hours instead of days, which has important implications for antimicrobial stewardship. However, the same study demonstrates that discrepancies between systems occur, highlighting the continued need for robust QC programs even with advanced technology. ### Genomic Approaches and Their Limitations Genomic methods for antimicrobial resistance detection are advancing rapidly. The [NCBI Pathogen Detection](https://www.ncbi.nlm.nih.gov/pathogens) program collects and analyzes pathogen genomic data for resistance determinants. The [chemical genomic screening protocol](https://doi.org/10.1128/msystems.00885-25) describes high-throughput approaches for linking gene function to phenotype under defined conditions. These genomic approaches complement but do not replace phenotypic AST. Genotypic resistance detection identifies resistance genes, but phenotypic testing measures actual antimicrobial activity. The [fallow deer microbiome protocol](https://doi.org/10.1016/j.xpro.2026.104498) demonstrates how metagenomic approaches can characterize the resistome of complex samples, but these methods are not yet standard for clinical AST QC. ## Safety and Regulatory Context ### Regulatory Expectations for QC Programs Regulatory bodies expect clinical laboratories to maintain robust QC programs for antimicrobial susceptibility testing. The specific requirements vary by laboratory type and accreditation body, but the underlying expectation is consistent: laboratories must demonstrate that their testing systems produce accurate and reliable results. The [CLSI standards](https://clsi.org/standards/products/microbiology) provide the technical basis for QC programs, while accreditation bodies assess compliance with these standards. Documentation of QC failures and corrective actions is a standard component of regulatory inspections. ### Public Health Implications of QC Failures Accurate AST results are essential for antimicrobial resistance surveillance. The [World Health Organization](https://www.who.int/health-topics/antimicrobial-resistance) monitors global resistance patterns and uses this information to inform treatment guidelines and public health policy. Inaccurate results from individual laboratories can distort surveillance data and lead to inappropriate public health decisions. The [FDA Bacteriological Analytical Manual](https://www.fda.gov/food/laboratory-methods-food/bacteriological-analytical-manual-bam) describes quality requirements for food microbiology testing that parallel clinical laboratory requirements. These official methods emphasize the importance of quality control for producing reliable results that support regulatory decisions. ### Professional Escalation Criteria Laboratories should have clear criteria for escalating QC failures beyond the laboratory. These criteria should include failures that persist after corrective action, failures that affect patient safety, and failures that suggest a systemic problem with a testing system or reagent lot. Escalation may involve contacting the instrument manufacturer, the reagent manufacturer, the standard-setting organization, or the laboratory's accrediting body. The [American Society for Microbiology](https://asm.org/) provides professional resources and networks that can support laboratories facing complex QC problems. ## A Practical Decision Framework for QC Failure Triage and Escalation When a QC result falls outside the acceptable range, laboratory staff face an immediate decision under time pressure. The natural impulse is to repeat the test quickly and hope for an in-range result, but this approach can mask an ongoing system failure and delay the identification of a root cause that will recur. A structured triage framework helps staff classify the severity of the failure, determine the appropriate investigation depth, and decide when to escalate beyond the laboratory. This section provides a practical decision framework that complements the systematic root-cause analysis workflow by focusing on the judgment calls that occur at each stage of the investigation. ### The Triage Matrix for Initial Response The first five minutes after a QC failure should follow a predictable sequence that prevents wasted effort and ensures consistent handling across shifts and operators. The triage matrix below organizes the initial response into three severity levels based on the pattern of failure and the potential impact on patient results. | Severity Level | Failure Pattern | Initial Response | Patient Result Status | Escalation Timeline | | --- | --- | --- | --- | --- | | Level 1 | Single agent, single organism, single run | Verify the result against the current range table and check transcription | Continue reporting other agents while investigating the affected agent | Resolve within one working day | | Level 2 | Multiple agents or multiple organisms in one run | Halt reporting for affected agents, review recent QC trends, check media and reagent lots | Withhold affected results pending investigation | Resolve within one working day or escalate | | Level 3 | Widespread failure across agents and organisms | Halt all AST reporting, initiate full root-cause investigation immediately | Suspend all AST patient testing | Escalate to supervisor within two hours | The severity level determines how much investigation is appropriate before repeating the test. A Level 1 failure involving a single agent may warrant a quick check of the specific disk or well before a repeat test. A Level 3 failure requires a complete system review before any repeat testing occurs, because repeating the test under the same conditions will likely produce the same failure. ### Decision Point One: Confirm Before Investigating The first decision point occurs before any investigation begins. Confirm that the QC result actually falls outside the acceptable range by checking three things: the current range table, the identity of the QC organism, and the transcription of the result. The [CLSI antimicrobial susceptibility testing standards](https://clsi.org/standards/products/microbiology) are periodically revised, and using an outdated range table can produce false failures that waste investigation time and delay patient results. Check the QC organism identity against the expected strain for the test being performed. A mix-up between QC strains or the use of a passaged strain that has drifted from its documented characteristics can produce out-of-range results that do not reflect a system problem. The [American Type Culture Collection](https://www.atcc.org/) maintains authenticated reference strains with documented phenotypic characteristics, and laboratories should verify that their working cultures trace back to authenticated sources. Transcription errors are more common than most laboratories acknowledge. The result recorded in the QC log may differ from the actual reading on the plate or instrument display. Verify the recorded result against the original reading before proceeding with the investigation. ### Decision Point Two: Classify the Failure Pattern Once the failure is confirmed, classify the pattern before deciding on the investigation approach. The pattern provides the first clue about the likely root cause and determines which variables to examine first. A single agent failing across one or multiple QC organisms suggests a problem specific to that antimicrobial agent or its testing materials. Check the disk lot, the well position, or the reagent preparation for that specific agent. A group of agents failing together may indicate a problem with a class of compounds, a specific panel, or a shared reagent. All agents failing across all organisms points to a systemic issue such as inoculum preparation, media quality, or instrument function. The [comparison study of rapid AST systems](https://doi.org/10.1128/jcm.01073-25) demonstrates that even well-functioning automated systems show categorical agreement rates around 94 percent and essential agreement rates around 96 percent when compared with each other. This means that discrepancies between systems occur even under normal operating conditions. When classifying a failure pattern, consider whether the observed result represents a true system failure or a known limitation of the testing method. ### Decision Point Three: Determine Investigation Depth The investigation depth should match the severity level and the failure pattern. A Level 1 failure with an obvious cause such as an expired disk may require only a check of the expiration date and a replacement before repeating the test. A Level 3 failure requires a systematic examination of every variable in the testing pathway. The investigation should follow a logical sequence that moves from the most common and easily corrected causes to the less common and more complex ones. Start with the consumables: check expiration dates, storage conditions, and lot numbers for all media and reagents used in the test. Then examine the inoculum preparation, including the turbidity standard, the timing between preparation and inoculation, and the purity of the culture. Then assess the instrument function, including temperature logs, calibration records, and maintenance history. Finally, review operator technique through direct observation or review of the testing records. The [Bacteriological Analytical Manual](https://www.fda.gov/food/laboratory-methods-food/bacteriological-analytical-manual-bam) from the FDA describes similar quality principles for food microbiology testing. While the specific methods differ from clinical AST, the underlying concept remains consistent: reference materials with known characteristics allow laboratories to verify that their testing systems produce accurate results. The same systematic approach to troubleshooting applies across microbiology disciplines. ### Decision Point Four: Decide When to Repeat the Test The decision to repeat the test should come after corrective action, not before investigation. Repeating the test without identifying and correcting the root cause risks reproducing the same failure and wasting time. However, there are situations where a repeat test is appropriate as part of the investigation itself. If the initial investigation identifies a specific cause such as an expired reagent or a contaminated inoculum, correct the problem and repeat the test to verify that the correction resolves the failure. If the initial investigation does not identify a cause, consider whether the failure may be a random event. A single failure with no identifiable cause and no recurrence on repeat testing may represent a transient event such as a momentary instrument glitch or a minor technique variation. The number of repeat tests required after corrective action depends on the nature of the failure and the requirements of the laboratory's quality program. A single successful repeat may be sufficient for an obvious cause such as expired media. A more complex failure that required extensive investigation may require multiple consecutive successful runs to verify system stability before patient results are reported. ### Decision Point Five: Apply Escalation Criteria Escalation criteria should be defined in advance so that the decision to involve outside support is automatic instead of improvised. The following situations warrant escalation beyond the initial investigation: A failure that persists after corrective action and repeat testing indicates that the root cause has not been identified. Continuing to investigate without progress wastes time and delays patient results. Escalate to the supervisor or quality manager who can bring additional expertise and authority to the investigation. A failure that affects multiple lots of media or reagents suggests a manufacturing problem instead of a laboratory problem. Contact the manufacturer with the lot numbers and observed results. The manufacturer may have information about known issues with the lot or may request samples for testing. A failure that cannot be explained after a thorough investigation may require consultation with the instrument manufacturer, the reagent manufacturer, or the standard-setting organization. The [American Society for Microbiology](https://asm.org/) provides professional resources and networks that can support laboratories facing complex QC problems. A failure that suggests a patient safety risk requires immediate escalation to the laboratory director and the medical director. This situation may involve reporting results that were generated during the period when QC was out of range, requiring a risk assessment and potentially a notification to affected clinicians. ### The Escalation Ladder in Practice The escalation ladder provides a structured path from initial investigation through internal escalation to external support. Each rung of the ladder has specific triggers and expected actions. The first rung is the bench-level investigation conducted by the operator who performed the test. This investigation follows the systematic workflow and should be completed within a defined time frame, typically one to two hours for a Level 1 or Level 2 failure. The second rung is the supervisor or quality manager review. This escalation occurs when the bench-level investigation does not identify a cause, when the failure persists after corrective action, or when the failure is classified as Level 3. The supervisor brings additional experience and authority to the investigation and can authorize more extensive corrective actions. The third rung is the laboratory director or quality officer involvement. This escalation occurs when the failure affects patient results, when the investigation requires resources beyond the laboratory, or when the failure suggests a systemic problem that may affect other testing areas. The fourth rung is external support from the manufacturer, the standard-setting organization, or a reference laboratory. This escalation occurs when the failure persists despite thorough investigation, when the failure suggests a manufacturing problem, or when the laboratory lacks the expertise to resolve the issue. The [total laboratory automation review](https://doi.org/10.3343/alm.2024.0581) describes how automated systems integrate pre-analytical, analytical, and post-analytical phases in clinical laboratories. These systems enhance quality control through error minimization, but they also introduce new failure modes that require systematic troubleshooting. When automated systems fail, the escalation path may include the instrument manufacturer's technical support team, who can access diagnostic data and service records that are not available to laboratory staff. ### Documenting Triage Decisions Every triage decision should be documented, including the severity level assigned, the rationale for that assignment, the investigation steps taken, and the escalation decisions made. This documentation serves multiple purposes: it provides evidence of regulatory compliance, it supports continuous quality improvement by identifying patterns in QC failures and responses, and it creates a reference for future troubleshooting. The documentation should capture the time of each decision point. Time stamps on the initial failure, the confirmation, the classification, the investigation steps, and the escalation decisions provide a complete timeline that can be reviewed after the event to identify delays or missed opportunities for earlier escalation. The [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html) guidelines from CDC and NIH emphasize the importance of maintaining accurate records in laboratory operations. While the primary focus of these guidelines is safety, the documentation principles apply equally to quality activities. Complete records transform troubleshooting from guesswork into systematic investigation. ### Common Triage Errors and How to Avoid Them Several common errors undermine effective triage of QC failures. Recognizing these errors helps laboratory staff avoid them. The first error is repeating the test before investigating. This approach wastes time when the same failure recurs and delays the identification of the root cause. The repeat test should be a verification step after corrective action, not a substitute for investigation. The second error is investigating too deeply for a simple failure. A Level 1 failure with an obvious cause such as an expired disk does not require a full system review. Matching the investigation depth to the severity level saves time and resources. The third error is failing to escalate when escalation is warranted. This error often occurs because laboratory staff want to resolve the problem independently or because they do not recognize the signs that the investigation is not progressing. Predetermined escalation criteria prevent this error by making the decision automatic. The fourth error is suspending patient testing unnecessarily. A Level 1 failure affecting a single agent may not require suspension of all AST testing. The decision to suspend testing should be based on the severity level and the potential impact on patient results, not on a blanket policy that treats all failures equally. The fifth error is failing to document triage decisions. Without documentation, the laboratory cannot demonstrate regulatory compliance, cannot identify patterns in QC failures, and cannot learn from past investigations. Documentation should be completed at each decision point, not reconstructed after the event. ### Integrating Triage with the Root-Cause Analysis Workflow The triage framework and the root-cause analysis workflow work together as a complete response system. The triage framework guides the initial response and the escalation decisions. The root-cause analysis workflow guides the technical investigation once the severity level and failure pattern are understood. The triage framework answers the question of how to respond. The root-cause analysis workflow answers the question of what to investigate. Together, they provide a complete response to QC failures that is systematic, efficient, and defensible. The [World Health Organization antimicrobial resistance program](https://www.who.int/health-topics/antimicrobial-resistance) monitors resistance patterns worldwide and emphasizes the importance of reliable susceptibility data for surveillance and stewardship. Laboratories that produce inaccurate AST results contribute misleading information to local, national, and global resistance databases, potentially distorting treatment guidelines and public health interventions. A structured triage framework that ensures consistent and thorough response to QC failures supports the production of reliable susceptibility data that can be trusted by clinicians and public health authorities. ### Practical Implementation of the Triage Framework Implementing the triage framework requires more than posting a flowchart on the wall. The framework must be integrated into the laboratory's standard operating procedures, staff must be trained in its use, and its effectiveness must be reviewed regularly. Start by adapting the triage matrix to the laboratory's specific testing systems, organisms, and antimicrobial panels. The severity levels and escalation timelines should reflect the laboratory's workflow and the clinical impact of delayed results. Involve bench-level staff in this adaptation process so that the framework reflects the realities of daily practice. Train all staff who perform AST on the triage framework, including the severity levels, the decision points, and the escalation criteria. Use case-based training that presents realistic QC failure scenarios and asks staff to apply the framework to determine the appropriate response. This training should be repeated regularly to maintain proficiency and to incorporate lessons learned from actual QC failures. Review the effectiveness of the triage framework after each QC failure investigation. Did the framework guide the response appropriately? Were the severity levels accurate? Were the escalation timelines realistic? Were there any situations where the framework did not provide adequate guidance? Use this review to refine the framework and to identify additional training needs. The [American Society for Microbiology](https://asm.org/) emphasizes the importance of standardized laboratory practices and professional development in microbiology. The triage framework represents a standardized approach to QC failure response that supports consistent practice across shifts and operators. Regular training and review ensure that the framework remains effective and that staff remain proficient in its use. ## Frequently Asked Questions ### What is the first step when a QC result falls outside the acceptable range? Confirm that the result actually falls outside the range by checking the current standard and verifying that the correct QC organism and antimicrobial agent were tested. Transcription errors and outdated range tables can produce apparent failures that do not reflect actual system problems. ### How many repeat QC tests are needed after corrective action? The number of repeat tests depends on the nature of the failure and the requirements of the laboratory's quality program. A single successful repeat may suffice for an obvious cause such as expired media, while complex failures may require multiple consecutive successful runs to verify system stability. ### Can patient results be reported while QC is out of range? Patient results should not be reported when QC results are out of range because the accuracy of the testing system is not verified. The decision to suspend or continue testing should follow predetermined criteria that consider the nature and extent of the QC failure. ### What is the most common cause of QC failures in antimicrobial susceptibility testing? Inoculum preparation errors are among the most common causes of QC failures. Incorrect turbidity standards, improper dilution, and delays between preparation and inoculation can all shift MIC results outside acceptable ranges. ### How often should QC strains be replaced? QC strains should be replaced according to the laboratory's quality program and the recommendations of the strain supplier. Excessive subculturing can select for variants with altered susceptibility profiles, so laboratories should follow recommended subculture limits. ### What should be documented during a QC failure investigation? Document the date and time of the failure, the QC organism and antimicrobial agent, the observed and expected results, all investigation steps, the root cause identified, and the corrective action implemented. Complete documentation supports regulatory compliance and continuous quality improvement. ### When should the instrument manufacturer be contacted? Contact the manufacturer when instrument malfunctions persist after basic troubleshooting, when failures cannot be explained after thorough investigation, or when the instrument produces error messages that indicate a need for service. Manufacturer technical support can provide specialized knowledge beyond what is available in the laboratory. ### How do rapid AST systems affect QC requirements? Rapid AST systems require the same fundamental QC principles as traditional methods, but they introduce new considerations related to automation and speed. Laboratories should verify that automated systems perform within specified parameters and should understand the limitations of any testing system, including the potential for discrepancies between systems. ## Related Bacteriology Guides - [Biological Foundation Models for Antimicrobial Peptide Discovery in Veterinary Pathogens](/knowledge/bacteria/general/biological-foundation-models-for-antimicrobial-peptide-discovery-in-veterinary-pathogens) - [Fowl Cholera in Poultry: Antimicrobial Therapy and Control](/knowledge/bacteria/avian-bacteria/fowl-cholera-drug-choice) - [Mycoplasma gallisepticum and Mycoplasma synoviae Infections in Chickens: Laboratory Diagnosis and Control Strategies](/knowledge/bacteria/avian-bacteria/chicken-mycoplasma-test) - [Avian Influenza in Wales: Surveillance and Control](/knowledge/bacteria/avian-bacteria/avian-influenza-wales-surveillance-control) - [Colibacillosis in Poultry: Pathogenesis, Diagnosis, and Control](/knowledge/bacteria/avian-bacteria/colibacillosis-in-poultry) ## References and Further Reading - [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html). CDC and NIH. - [Microbiology Resources](https://asm.org/). American Society for Microbiology. - [Antimicrobial Resistance](https://www.who.int/health-topics/antimicrobial-resistance). World Health Organization. - [Bacteriological Analytical Manual](https://www.fda.gov/food/laboratory-methods-food/bacteriological-analytical-manual-bam). U.S. Food and Drug Administration. - [Antimicrobial Susceptibility Testing](https://clsi.org/standards/products/microbiology). Clinical and Laboratory Standards Institute. - [Culture Collections](https://www.atcc.org/). American Type Culture Collection. - [NCBI Pathogen Detection](https://www.ncbi.nlm.nih.gov/pathogens). National Center for Biotechnology Information. - [Comparison of the VITEK REVEAL AST and Accelerate Pheno systems for fast antimicrobial susceptibility testing of gram-negative blood cultures at a large academic health system.](https://doi.org/10.1128/jcm.01073-25). 2026. - [High-throughput chemical genomic screening: a step-by-step workflow from plate to phenotype.](https://doi.org/10.1128/msystems.00885-25). 2025. - [Protocol for the assessment of the impact of mycotoxins and glyphosate residues on the gut microbiome and resistome of European fallow deer.](https://doi.org/10.1016/j.xpro.2026.104498). 2026. - [Revolutionizing Laboratory Practices: Pioneering Trends in Total Laboratory Automation.](https://doi.org/10.3343/alm.2024.0581). 2025. > This article is educational and does not replace validated laboratory procedures, clinical diagnosis, institutional biosafety review, or public-health guidance.